Combining chemical genomics screens in yeast to reveal spectrum of effects of chemical inhibition of sphingolipid biosynthesis

BMC Microbiology

Volumn 9, Issue , 2009, Pages

  Kemmer, Danielle ^a   McHardy, Lianne M ^a   Hoon, Shawn ^b   Rebérioux, Delphine ^a   Giaever, Guri ^c,d   Nislow, Corey ^c,d   Roskelley, Calvin D ^a   Roberge, Michel ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CYTOCHROME C SYNTHETASE; DIHYDROMOTUPORAMINE C; LYASE; PROPYLAMINE; SINGLE HETEROCYCLIC RINGS; SPHINGOLIPID;

ANTIFUNGAL RESISTANCE; ARTICLE; BIOSYNTHESIS; CELL DEATH; DRUG EFFECT; FUNGAL GENE; GENE DOSAGE; GENE EXPRESSION REGULATION; GENETICS; GENOMICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MITOCHONDRION; PH; PHYSIOLOGY; SACCHAROMYCES CEREVISIAE; TRANSPORT VESICLE; TUMOR CELL LINE;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ANTINEOPLASTIC AGENTS; CELL DEATH; CELL LINE, TUMOR; DRUG RESISTANCE, FUNGAL; GENE DOSAGE; GENE EXPRESSION REGULATION, FUNGAL; GENES, FUNGAL; GENOMICS; HETEROCYCLIC COMPOUNDS, 1-RING; HUMANS; HYDROGEN-ION CONCENTRATION; LYASES; MICROBIAL SENSITIVITY TESTS; MITOCHONDRIA; PROPYLAMINES; SACCHAROMYCES CEREVISIAE; SPHINGOLIPIDS; TRANSPORT VESICLES;

EID: 60149112533     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-9-9     Document Type: Article

References (53)

1. Yeast as a tool to uncover the cellular targets of drugs. CM Sturgeon D Kemmer HJ Anderson M Roberge, Biotechnol J 2006 1 3 289 298 10.1002/biot. 200500039 16897709
2. Yeast as a model system for anticancer drug discovery. JA Simon A Bedalov, Nat Rev Cancer 2004 4 6 481 492 10.1038/nrc1372 15170450
3. A genome-wide overexpression screen in yeast for small-molecule target identification. H Luesch TY Wu P Ren NS Gray PG Schultz F Supek, Chem Biol 2005 12 1 55 63 10.1016/j.chembiol.2004.10.015 15664515
4. Genomic profiling of drug sensitivities via induced haploinsufficiency. G Giaever DD Shoemaker TW Jones H Liang EA Winzeler A Astromoff RW Davis, Nat Genet 1999 21 3 278 283 10.1038/6791 10080179
5. Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes. PY Lum CD Armour SB Stepaniants G Cavet MK Wolf JS Butler JC Hinshaw P Garnier GD Prestwich A Leonardson P Garrett-Engele CM Rush M Bard G Schimmack JW Phillips CJ Roberts DD Shoemaker, Cell 2004 116 1 121 137 10.1016/S0092-8674(03)01035-3 14718172
6. Yeast genome-wide drug-induced haploinsufficiency screen to determine drug mode of action. K Baetz L McHardy K Gable T Tarling D Reberioux J Bryan RJ Andersen T Dunn P Hieter M Roberge, Proc Natl Acad Sci USA 2004 101 13 4525 4530 15070751 10.1073/pnas.0307122101
7. Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways. AB Parsons RL Brost H Ding Z Li C Zhang B Sheikh GW Brown PM Kane TR Hughes C Boone, Nat Biotechnol 2004 22 1 62 69 10.1038/nbt919 14661025
8. Exploring the Mode-of-Action of Bioactive Compounds by Chemical-Genetic Profiling in Yeast. AB Parsons A Lopez IE Givoni DE Williams CA Gray J Porter G Chua R Sopko RL Brost CH Ho J Wang T Ketela C Brenner JA Brill GE Fernandez TC Lorenz GS Payne S Ishihara Y Ohya B Andrews TR Hughes BJ Frey TR Graham RJ Andersen C Boone, Cell 2006 126 3 611 625 10.1016/j.cell.2006.06.040 16901791
9. Targeted selection of recombinant clones through gene dosage effects. J Rine W Hansen E Hardeman RW Davis, Proc Natl Acad Sci USA 1983 80 22 6750 6754 6316322 10.1073/pnas.80.22.6750
10. Reactive oxygen species in mitochondria-mediated cell death. S Orrenius, Drug Metab Rev 2007 39 2-3 443 455 10.1080/03602530701468516 17786631
11. Four deaths and a funeral: from caspases to alternative mechanisms. M Leist M Jaattela, Nat Rev Mol Cell Biol 2001 2 8 589 598 10.1038/35085008 11483992
12. Accelerating the discovery of biologically active small molecules using a high-throughput yeast halo assay. NC Gassner CM Tamble JE Bock N Cotton KN White K Tenney RP St Onge MJ Proctor G Giaever C Nislow RW Davis P Crews TR Holman RS Lokey, J Nat Prod 2007 70 3 383 390 17291044 10.1021/np060555t
13. Canadian Chemical Biology Network. http://www.ccbn-rcbc.ca/
14. Designer deletion strains derived from Saccharomyces cerevisiae S288C: a useful set of strains and plasmids for PCR-mediated gene disruption and other applications. CB Brachmann A Davies GJ Cost E Caputo J Li P Hieter JD Boeke, Yeast 1998 14 2 115 132 10.1002/(SICI)1097-0061(19980130)14:2〈115::AID- YEA204〉3.0.CO;2-2 9483801
15. The Pleitropic Drug ABC Transporters from Saccharomyces cerevisiae. A Decottignies B Rogers M Kolaczkowski E Carvajal E Balzi C Gwenaelle N Kyoko A Di Pietro BC Monk A Goffeau, Horizon Scientific Press 2002
16. Localization in yeast mitochondrial DNA of mutations expressed in a deficiency of cytochrome oxidase and/or coenzyme QH2-cytochrome c reductase. PP Slonimski A Tzagoloff, Eur J Biochem 1976 61 1 27 41 10.1111/j.1432-1033.1976. tb09994.x 173553
17. Retrograde regulation of multidrug resistance in Saccharomyces cerevisiae. WS Moye-Rowley, Gene 2005 354 15 21 10.1016/j.gene.2005.03.019 15896930
18. The identification of myriocin-binding proteins. JK Chen WS Lane SL Schreiber, Chem Biol 1999 6 4 221 235 10.1016/S1074-5521(99)80038-6 10099133
19. Inhibition of tumor cell invasion and angiogenesis by motuporamines. CD Roskelley DE Williams LM McHardy KG Leong A Troussard A Karsan RJ Andersen S Dedhar M Roberge, Cancer Res 2001 61 18 6788 6794 11559552
20. Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model. J Kornhuber P Tripal M Reichel L Terfloth S Bleich J Wiltfang E Gulbins, J Med Chem 2008 51 2 219 237 10.1021/jm070524a 18027916
21. An integrated platform of genomic assays reveals small-molecule bioactivities. S Hoon AM Smith IM Wallace S Suresh M Miranda E Fung M Proctor KM Shokat C Zhang RW Davis G Giaever RP St Onge C Nislow, Nat Chem Biol 2008 4 8 498 506 10.1038/nchembio.100 18622389
22. Yeast mitochondrial F1F0-ATP synthase exists as a dimer: identification of three dimer-specific subunits. I Arnold K Pfeiffer W Neupert RA Stuart H Schagger, Embo J 1998 17 24 7170 7178 9857174 10.1093/emboj/17.24.7170
23. Mitochondrial acyl carrier protein is involved in lipoic acid synthesis in Saccharomyces cerevisiae. S Brody C Oh U Hoja E Schweizer, FEBS Lett 1997 408 2 217 220 10.1016/S0014-5793(97)00428-6 9187370
24. Hyperosmotic stress induces metacaspase- and mitochondria-dependent apoptosis in Saccharomyces cerevisiae. RD Silva R Sotoca B Johansson P Ludovico F Sansonetty MT Silva JM Peinado M Corte-Real, Mol Microbiol 2005 58 3 824 834 10.1111/j.1365-2958.2005.04868.x 16238630
25. Identification and sequence of the gene encoding cytochrome c heme lyase in the yeast Saccharomyces cerevisiae. ME Dumont JF Ernst DM Hampsey F Sherman, Embo J 1987 6 1 235 241 3034577
26. Coupling of heme attachment to import of cytochrome c into yeast mitochondria. Studies with heme lyase-deficient mitochondria and altered apocytochromes c. ME Dumont JF Ernst F Sherman, J Biol Chem 1988 263 31 15928 15937 2846529
27. Role of mitochondria and C-terminal membrane anchor of Bcl-2 in Bax induced growth arrest and mortality in Saccharomyces cerevisiae. W Greenhalf C Stephan B Chaudhuri, FEBS Lett 1996 380 1-2 169 175 10.1016/0014-5793(96)00044-0 8603730
28. Systematic genetic analysis with ordered arrays of yeast deletion mutants. AH Tong M Evangelista AB Parsons H Xu GD Bader N Page M Robinson S Raghibizadeh CW Hogue H Bussey B Andrews M Tyers C Boone, Science 2001 294 5550 2364 2368 10.1126/science.1065810 11743205
29. A genomic screen for yeast vacuolar membrane ATPase mutants. M Sambade M Alba AM Smardon RW West PM Kane, Genetics 2005 170 4 1539 1551 15937126 10.1534/genetics.105.042812
30. The chemical genomic portrait of yeast: uncovering a phenotype for all genes. ME Hillenmeyer E Fung J Wildenhain SE Pierce S Hoon W Lee M Proctor RP St Onge M Tyers D Koller RB Altman RW Davis C Nislow G Giaever, Science 2008 320 5874 362 365 10.1126/science.1150021 18420932
31. The vacuolar (H+)-ATPases - nature's most versatile proton pumps. T Nishi M Forgac, Nat Rev Mol Cell Biol 2002 3 2 94 103 10.1038/nrm729 11836511
32. Multiple methods of visualizing the yeast vacuole permit evaluation of its morphology and inheritance during the cell cycle. LS Weisman R Bacallao W Wickner, J Cell Biol 1987 105 4 1539 1547 2444598 10.1083/jcb.105.4.1539
33. Characterization of Schizosaccharomyces pombe mutants defective in vacuolar acidification and protein sorting. T Iwaki T Goa N Tanaka K Takegawa, Mol Genet Genomics 2004 271 2 197 207 10.1007/s00438-003-0971-7 14735354
34. Receptor downregulation and multivesicular-body sorting. DJ Katzmann G Odorizzi SD Emr, Nat Rev Mol Cell Biol 2002 3 12 893 905 10.1038/nrm973 12461556
35. Cells depleted of mitochondrial DNA (rho0) yield insight into physiological mechanisms. NS Chandel PT Schumacker, FEBS Lett 1999 454 3 173 176 10.1016/S0014-5793(99)00783-8 10431801
36. Carbon monoxide signals via inhibition of cytochrome c oxidase and generation of mitochondrial reactive oxygen species. BS Zuckerbraun BY Chin M Bilban J de Costa d'Avila J Rao TR Billiar LE Otterbein, Faseb J 2007 21 4 1099 1106 10.1096/fj.06-6644com 17264172
37. Mitochondrial complex III is required for hypoxia-induced ROS production and gene transcription in yeast. RD Guzy MM Mack PT Schumacker, Antioxid Redox Signal 2007 9 9 1317 1328 10.1089/ars.2007.1708 17627464
38. Mitochondrial reactive oxygen species affect sensitivity to curcumin-induced apoptosis. H Numsen Jr, Free Radic Biol Med 2008 44 7 1382 1393 10.1016/j.freeradbiomed.2007.12.034 18206126
39. Are mitochondria a spontaneous and permanent source of reactive oxygen species? H Nohl L Gille A Kozlov K Staniek, Redox Rep 2003 8 3 135 141 10.1179/135100003225001502 12935310
40. Isc1 regulates sphingolipid metabolism in yeast mitochondria. H Kitagaki LA Cowart N Matmati S Vaena de Avalos SA Novgorodov YH Zeidan J Bielawski LM Obeid YA Hannun, Biochim Biophys Acta 2007 1768 11 2849 2861 17880915 10.1016/j.bbamem.2007.07.019
41. Isc1p Plays a Key Role in Hydrogen Peroxide Resistance and Chronological Lifespan through Modulation of Iron Levels and Apoptosis. T Almeida M Marques D Mojzita MA Amorim RD Silva B Almeida P Rodrigues P Ludovico S Hohmann P Moradas-Ferreira M Corte-Real V Costa, Mol Biol Cell 2008 19 3 865 876 18162582 10.1091/mbc.E07-06-0604
42. eIF2 independently binds two distinct eIF2B subcomplexes that catalyze and regulate guanine-nucleotide exchange. GD Pavitt KV Ramaiah SR Kimball AG Hinnebusch, Genes Dev 1998 12 4 514 526 9472020 10.1101/gad.12.4.514
43. Anticancer drugs, ionophoric peptides, and steroids as substrates of the yeast multidrug transporter Pdr5p. M Kolaczkowski M van der Rest A Cybularz-Kolaczkowska JP Soumillion WN Konings A Goffeau, J Biol Chem 1996 271 49 31543 31548 10.1074/jbc.271.49.31543 8940170
44. Sphingolipid requirement for generation of a functional v1 component of the vacuolar ATPase. JH Chung RL Lester RC Dickson, J Biol Chem 2003 278 31 28872 28881 10.1074/jbc.M300943200 12746460
45. Functions and metabolism of sphingolipids in Saccharomyces cerevisiae. RC Dickson C Sumanasekera RL Lester, Prog Lipid Res 2006 45 6 447 465 10.1016/j.plipres.2006.03.004 16730802
46. Sphingoid base synthesis requirement for endocytosis in Saccharomyces cerevisiae. B Zanolari S Friant K Funato C Sutterlin BJ Stevenson H Riezman, Embo J 2000 19 12 2824 2833 10856228 10.1093/emboj/19.12.2824
47. The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. Y Yarden, Eur J Cancer 2001 37 Suppl 4 S3 8 10.1016/S0959-8049(01)00230-1 11597398
48. Epidermal growth factor (EGF) increases the in vitro invasion, motility and adhesion interactions of the primary renal carcinoma cell line, A704. JT Price HM Wilson NE Haites, Eur J Cancer 1996 32A 11 1977 1982 10.1016/0959-8049(96)00207-9 8943684
49. EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells. T Turner P Chen LJ Goodly A Wells, Clin Exp Metastasis 1996 14 4 409 418 10.1007/BF00123400 8878415
50. Epidermal growth factor receptor overexpression results in increased tumor cell motility in vivo coordinately with enhanced intravasation and metastasis. C Xue J Wyckoff F Liang M Sidani S Violini KL Tsai ZY Zhang E Sahai J Condeelis JE Segall, Cancer Res 2006 66 1 192 197 10.1158/0008-5472.CAN-05- 1242 16397232
51. Motuporamines, anti-invasion and anti-angiogenic alkaloids from the marine sponge Xestospongia exigua (Kirkpatrick): isolation, structure elucidation, analogue synthesis, and conformational analysis. DE Williams KS Craig B Patrick LM McHardy R van Soest M Roberge RJ Andersen, J Org Chem 2002 67 1 245 258 10.1021/jo016101c 11777468
52. Studies on the transformation of intact yeast cells by the LiAc/SS-DNA/PEG procedure. RD Gietz RH Schiestl AR Willems RA Woods, Yeast 1995 11 4 355 360 10.1002/yea.320110408 7785336
53. A unique and universal molecular barcode array. SE Pierce EL Fung DF Jaramillo AM Chu RW Davis C Nislow G Giaever, Nat Methods 2006 3 8 601 603 10.1038/nmeth905 16862133